46 top medical experts on Erythrasma across 7 countries and 3 U.S. states, including 4 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Erythrasma: A chronic bacterial infection of major folds of the skin, caused by Corynebacterium minutissimum.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Bacterial Skin Diseases (1,358), Corynebacterium Infections (2,158).


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Cohen, Philip R   Dermatology  Google Publications
    Physician  Case Reports 
    Disclosed payments from biomedical company (SUN PHARMACEUTICAL INDUSTRIES INC.) in 2021 for $104.65
    Subjects: Anti-Bacterial Agents; Clarithromycin; Mupirocin
    Categories: Administration & Dosage; Drug Therapy; Therapeutic Use
    Erythrasma: A report of nine men successfully managed with mupirocin 2% ointment monotherapy. (2017)
    Erythrasma: successful treatment after single-dose clarithromycin. (2013)

  2. Wilson, Barbara B   Dermatology  Google Publications
    Physician  Case Reports 
    Subjects: Vulvar Diseases
    Categories: Diagnosis
    An atypical presentation of erythrasma. (2012)

  3. Usatine, Richard P   Family Medicine   Google Publications
    University of Texas Health at San Antonio, San Antonio, TX, USA. E-mail: .
    Physician  Case Reports 
    Medical school: Columbia University College of Physicians and Surgeons (MD, 1982)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 58/100
    Subjects: Foot Diseases
    Categories: Diagnosis; Microbiology
    Persistent rash on feet. (2018)

  4. Chodkiewicz, Hubert M   MOHS-Micrographic Surgery  Google Publications
    Physician  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 57/100
    Disclosed payments in 2021 from 51 biomedical companies, totalling $1,128.77, including $138.39 from  VYNE Pharmaceuticals Inc.
    Subjects: Anti-Bacterial Agents; Clarithromycin
    Categories: Therapeutic Use; Drug Therapy
    Erythrasma: successful treatment after single-dose clarithromycin. (2013)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);